Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Enhance MD vs Peter MD

Enhance MD
Site position #5

Higher grade

vs+6.7
Peter MD
Site position #34

Lower grade

The verdict

Enhance MD takes it — 84.8/100 to 78.1/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnhance MD +2
82
80
Dose & formulationEven
82
82
Clinical oversightEnhance MD +8
88
80
Labs & monitoringEnhance MD +16
90
74
FulfillmentEnhance MD +6
84
78
Contract termsEnhance MD +18
84
66
Enhance MD · left barPeter MD · right bar

The numbers

MetricEnhance MDPeter MD
WeighScore84.8/10078.1/100
GradeBC+
Site position#5#34
Semaglutide$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay$139-149/mo (compounded w/ B12)
Tirzepatide$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay$149 first month, then $249/mo (quarterly)
CoverageNot publicly listedMost states — exclusions vary by treatment
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Enhance MD

Site position #5 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs
Peter MD

Site position #34 · C+

Strengths

  • Broad multi-category catalog on one account — TRT, GLP-1, ED, non-GLP-1 weight loss, men's hair loss and NAD+
  • Physician-prescribed, nationwide telehealth operating since 2021
  • Genuinely cheap TRT entry — $79/mo testosterone cypionate on a 12-month plan
  • Low tirzepatide first-month rate ($149) at a real 60mg dose

Where it loses points

  • Tirzepatide steps up from $149 the first month to $249/mo, billed quarterly
  • Semaglutide's own pricing is hard to compare at a glance — $149/mo for first-time patients vs $139/mo for returning ones, with very different total costs ($447 vs $834) over similar supply windows
  • The affiliate program discloses a wider list of state exclusions (varying by treatment, touching AL, AR, CA, ID, IA, KY, LA, MA, MI, NC, SC and TX) than any single customer-facing pricing page states
  • TRT and tirzepatide both require locking into quarterly or 12-month billing to get the advertised rate
  • No named medical director or lab/monitoring detail published; customer reviews are mixed

Featured provider

Enhance MD

Enhance MD scores 84.8/100 (B). A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard